Medidata Remote Source Review Software-as-a-Service for Electronic Monitoring of Clinical Studies

THIS IS A NOTICE OF INTENT AND NOT A REQUEST FOR QUOTATIONS

This notice is published in accordance with Federal Acquisition Regulation (FAR) 5.101(a)(1) requiring the dissemination of information regarding proposed contract actions. This is a Notice of Intent to award a sole source, firm-fixed price purchase order under the authority of 41 U.S.C. 3304(a)(1), as implemented by FAR 13.106-1(b)(2) and 13.501(a) - Only One Responsible Source and No Other Supplies or Service Will Satisfy Agency Requirements and is not a request for competitive proposals. 

The National Institute of Allergy and Infectious Diseases (NIAID) intends to negotiate on a sole source basis with Medidata Solutions, Inc. 350 Hudson St. #9, New York, New York 10014.   

This acquisition will renew Medidata Remote Source Review module licenses to manage clinical site monitoring performed by the Division of AIDS within the National Institute of Allergy and Infectious Diseases in a validated environment in accordance with federal and international regulations.  NIAID requires the procurement of Medidata licenses to continue to provide Remote Source Review capabilities for a 12-month period, with the option to expand the number of licenses if required.   

Period of Performance: June 24, 2022 – June 23, 2023.

The North American Industry Classification (NAICS) code for this acquisition is 518210 Data Processing, Hosting, and Related Services, which has a size standard of $35.0 million. Medidata Solutions is an other than small business.

This will be the only notice of the Government's intent to solicit, negotiate, and award to one source to satisfy this requirement.  The Government plans to award a contract for this requirement within 30 days of this notice.

While this synopsis does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy this requirement.  The Government understands that Medidata Solutions is the only vendor who can provide the requested services for NIAID.  However, firms that believe they can provide the capability required to fully meet the Government's requirement may submit a capabilities statement, including past performance, in writing to the identified point of contact within 15 days after publication of this notice.  Such documentation shall be evaluated solely for the purpose of determining whether or not to conduct this procurement on a competitive basis.  A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.  Interested parties may identify their interest and capability to respond to the requirement or submit offers on NOI-NIAID-2124304.

This notice does not obligate the Government to award a contract or otherwise pay for any information provided in response.  The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate.  Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work.  Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted.

For additional information or to submit responses, please contact Tamara McDermott, Contract Specialist at tamara.mcdermott@nih.gov.